View Author
dai: 075056976
scopus: 7201765517
Dongen, J.J.M. van
(Jacques van Dongen)Supervisor (promotor) of 13 dissertations
patient rearrangement leukemia analysis blood expression study b-cell sample level t-cell number lymphoblastic leukemia figure mutation result recombination b cells protein disease group lymphoblastic table region relapse lymphocytes receptor artemi treatment diagnosis detection clonal fication t-all target control subset immunol immunoglobulin development clonality childhood memory lymphoma chain deletion segment locus sequence precursor defect proliferation ficiency frequency response therapy product fusion signi dongen lymphocyte antibody assay erasmus mc population infant thymocyte value children protocol university sensitivity identi signal identi fied differentiation breakpoint department genomic van dongen jjm
10 Most Recent Publications
|
No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment
(Article)
Bras, A.E. Heuvel-Eibrink, M.M. van den Haas, V. de Dongen, J.J.M. van Velden, V.H.J. van der Sluijs-Gelling, A.J. van der Coenen, E.A. Wind, H.K. Zwaan, C.M. Marvelde, J.G. te Burg, M. van der Gibson, B. Rijneveld, A.W. |
2013-04-19
|
|
Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity
(Article)
Driessen, G.J.A. IJspeert, H. Zelm, M.C. van Dongen, J.J.M. van Deuren, M. van Burger, C.W. Weemaes, C.M.R. Haraldsson, A. Trip, M. Warris, A. Flier, M. van der Wulffraat, N.M. Verhagen, M.M.M. Taylor, M.A. |
2013-04-08
|
|
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood
(Article)
Aalbers, A.M. Heuvel-Eibrink, M.M. van den Schmugge, M. Stary, J. Zecca, M. Zwaan, C.M. Loosdrecht, A.A. van de Dongen, J.J.M. van Niemeyer, C.M. Velden, V.H.J. van der Haas, V. de Marvelde, J.G. te Jong, A.X. de Burg, M. van der Dworzak, M.N. Hasle, H. Locatelli, F. Moerloose, B. de |
2013-03-15
|
|
Combined TCRG and TCRA TREC analysis reveals increased peripheral T-lymphocyte but constant intra-thymic proliferative history upon ageing
(Article)
Weerd, K. van der Dik, W.A. Schrijver, B. Bogers, A.J.J.C. Maat, A.W.P.M. Nederveen, F.H. van Hagen, P.M. van Dongen, J.J.M. van Langerak, A.W. Staal, F.J.T. |
2013-03-01
|
|
Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia
(Article)
Denys, B. Sluijs-Gelling, A.J. van der Homburg, C.H. Schoot, C.E. van der Haas, V. de Philippé, J. Pieters, R. Dongen, J.J.M. van Velden, V.H.J. van der |
2013-03-01
|
|
The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation
(Article)
Piatosa, B. Burg, M. van der Siewiera, K. Pac, M. Dongen, J.J.M. van Langerak, A.W. Chrzanowska, K.H. Bernatowska, E. |
2012-10-01
|
|
The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells
(Article)
Vries, J.F. de Zwaan, C.M. Bie, M. de Voerman, J.S. Boer, M.L. den Dongen, J.J.M. van Velden, V.H.J. van der |
2012-02-01
|
|
Morbidly obese human subjects have increased peripheral blood CD4 + T cells with skewing toward a Treg- and Th2-dominated phenotype
(Article)
Weerd, K. van der Dik, W.A. Lelij, A.J. van der Staal, F.J.T. Hagen, P.M. van Schrijver, B. Schweitzer, D.H. Langerak, A.W. Drexhage, H.A. Kiewiet-Kemper, R.M. Aken, M.O. van Huisstede, A. van Dongen, J.J.M. van |
2012-02-01
|
|
New frontiers of primary antibody deficiencies
(Article)
Burger, C.W. Zelm, M.C. van Driessen, G.J.A. Dongen, J.J.M. van |
2012-01-01
|
|
B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency
(Article)
Driessen, G.J.A. Zelm, M.C. van Dongen, J.J.M. van Burg, M. van der Hagen, P.M. van Hartwig, N.G. Trip, M. Warris, A. Vries, E. de Barendregt, B.H. Pico, I. Hop, W.C.J. |
2011-12-22
|
